XXVII Curso Intensivo Davidson-Mestman, Diabetes, Endocrinology and Cardiometabolic Diseases

Wednesday, December 10, 2025, 8:30 AM - Saturday, December 13, 2025, 5:30 PM, JW Marriott Miami-Brickell, Miami, FL


AMA PRA Category 1 Credits™ (24.50 hours), Non-Physician Attendance (24.50 hours)

The XXVII Davidson-Mestman Intensive Course on Diabetes, Endocrinology and Cardiometabolic Diseases is the premier Endocrinology Congress reaching endocrinology specialists throughout Latin America, Spain and the USA. The course, commonly referred to as “Curso Intensivo,” will comprehensively address the daily challenges faced by physicians in clinical practice who treat patients with diabetes, cardiovascular disease, and endocrine disorders. The four-day “Curso Intensivo” lectures will be conducted in both English and Spanish and are designed for endocrinologists, internists, family doctors, and allied health care professionals.

1. Describe the current trends in research on emerging therapies on thyroid cancertargeting, their use and advantages
2. Explain the rationale for active surveillance and the inclusion and exclusion criteria for active surveillance in patient with micropapillary thyroid carcinoma
3. Define bariatric surgery and describe the different types of procedures commonly performed
4. Outline the clinical assessment for symptoms and signs of adrenal hormone excess, the diagnostic testing and management of adrenocorticoid carcinomas
5. List the common clinical presentations and symptoms associated with different types of pituitary tumors.
6. Contrast the key clinical features of rare bone diseases and explain the challenges associated with the diagnosis and management
7. Examine the global and local epidemiology of DKD as a major complication of diabetes.
8. Diagram a precise clinical approach to the diagnosis of adrenal tumors and contrast the current treatment available and their application on the treatment onadrenal tumors
9. Identify the physiological mechanisms by which specific endocrine hormones contribute to elevated blood pressure, List the key clinical features and signs and principles of diagnosis and treatment of endocrine hypertension.
10. Classify pituitary adenomas based on their size, location and describe the pathophysiology of common hormone hypersecretion syndromes associated with pituitary tumors
11. Explain the appropriate biochemical and hormonal testing used in the diagnosis of pituitary tumors and the appropriate treatment
12. Define Gestational Diabetes Mellitus (GDM) and differentiate it from pre-existing diabetes in pregnancy.
13. Outline the current screening and diagnostic criteria for GDM, including the timing and procedures for glucose challenge and oral glucose tolerance tests (OGTT)
14. Recognize the clinical significance of early detection and management of DKD to prevent adverse kidney and cardiovascular outcomes.
15. Explain the key pathophysiological mechanisms contributing to the development and progression of CKD, including the role of hyperglycemia, RAAS activation, inflammation, and fibrosis.
16. Revise the atherogenic lipoprotein profile commonly observed in diabetic patients and the characteristics of small dense Low-Density Lipoprotein (sdLDL) particles.
17. Identify the key factors that contribute to the formation of sdLDL in diabetic individuals.
18. Summarize the non-pharmacological management strategies for dyslipidemia in diabetic patients, including lifestyle modifications and the various classes of lipid-lowering medications and their mechanisms of action in the context of diabetic dyslipidemia.

Register here.

 

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 24.50 of AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST MITIGATION:
All conflicts of interest of any individual in a position to control the content of this CME activity will be identified and mitigated prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Cancellation Policy
University of Miami Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Registrations may be canceled until November 30th, and $200 will be refunded due to processing costs. After November 30th, no refunds will be issued, but the attendee’s name may be changed.

Accessibility Statement
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Manager: Diana Welch | email: [email protected]

JW Marriott Miami, 1109 Brickell Avenue, Miami, FL 33131

 

Mitigation of Relevant Financial Relationships

The University of Miami adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.